Enfermedades Infecciosas
Buscador de publicaciones
Sólo se han incluido artículos originales, editoriales y revisiones.
-
Pérez M, de Vinuesa AG, Sanchez-Duffhues G, Marquez N, Bellido ML, Muñoz-Fernandez MA, Moreno S, Castor TP, Calzado MA, Muñoz E.
Bryostatin-1 Synergizes with Histone Deacetylase Inhibitors to Reactivate HIV-1 from Latency
CURRENT HIV RESEARCH . 8(6): 418-429. Nº de citas: 90
-
Pérez-Molina JA, Serrano O, Milinkovic A, Domingo P, Currán A, Knobel H, Gaspar G, Rodrigo A, Jiménez-Expósito MJ, Hernández-Novoa B, Moreno S, The NUCREST Study.
Comparison of Antiviral Activity of Regimens Containing Nucleos(t)ide (NUC) Pairs in HIV-Infected Patients Initiating REScue Therapy (The NUCREST Study)
HIV CLINICAL TRIALS . 11(5): 294-302. Nº de citas: 1
-
Reekie J, Mocroft A, Ledergerber B, Beniowski M, Clotet B, van Lunzen J, Chiesi A, Pradier C, Machala L, Lundgren JD.
History of viral suppression on combination antiretroviral therapy as a predictor of virological failure after a treatment change*
HIV MEDICINE . 11(7): 469-478. Nº de citas: 27
-
Lodwick RK, Sabin CA, Porter K, Ledergerber B, van Sighem A, Cozzi-Lepri A, Khaykin P, Mocroft A, Jacobson L, De Wit S, Obel N, Castagna A, Wasmuth JC, Gill J, Klein MB, Gange S, Riera M, Mussini C, Gutiérrez F, Touloumi G, Carrieri P, Guest JL, Brockmeyer NH, Phillips AN.
Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per mu L in Europe and North America: a pooled cohort observational study
LANCET . 376(9738): 340-345. Nº de citas: 67
-
Norman FF, Pérez de Ayala A, Pérez-Molina JA, Monge-Maillo B, Zamarrón P, López-Vélez R.
Neglected tropical diseases outside the tropics.
PLOS NEGLECTED TROPICAL DISEASES . 4(7): . Nº de citas: 37
-
Martínez E, Larrousse M, Llibre JM, Gutiérrez F, Saumoy M, Antela A, Knobel H, Murillas J, Berenguer J, Pich J, Pérez I, Gatell JM.
Substitution of raltegravir for ritonavir-boosted protease inhibitors in HIV-infected patients: the SPIRAL study.
AIDS . 24(11): 1697-1707. Nº de citas: 145
-
Mocroft A, Kirk O, Reiss P, De Wit S, Sedlacek D, Beniowski M, Gatell J, Phillips AN, Ledergerber B, Lundgren JD.
Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients.
AIDS . 24(11): 1667-1678.
-
Barragán P, López-Velez R, Olmo M, Podzamczer D.
Visceral Leishmaniasis treated with antimonials/paromomycin followed by itraconazole/miltefosine after standard therapy failures in a human immunodeficiency virus-infected patient.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE . 83(1): 10-12. Nº de citas: 11
-
Lopez-Velez R, Batlle C, Jiménez C, Navarro M, Norman F, Perez-Molina J.
Short course combination therapy for giardiasis after nitroimidazole failure.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE . 83(1): 171-173. Nº de citas: 31
-
Arnáez J, Roa MA, Albert L, Cogollos R, Rubio JM, Villares R, Alarabe A, Cervera A, López-Vélez R.
Imported malaria in children: a comparative study between recent immigrants and immigrant travelers (VFRs).
JOURNAL OF TRAVEL MEDICINE . 17(4): 221-227. Nº de citas: 32
-
Poveda E, Anta L, Blanco JL, Casado JL, Gutiérrez F, García F, Gómez-Sirvent JL, Iribarren JA, Soriano V, de Mendoza C.
Drug Resistance Mutations in HIV-Infected Patients in the Spanish Drug Resistance Database Failing Tipranavir and Darunavir Therapy
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY . 54(7): 3018-3020. Nº de citas: 8
-
Poveda E, Alcamí J, Paredes R, Córdoba J, Gutiérrez F, Llibre JM, Delgado R, Pulido F, Iribarren JA, García Deltoro M, Hernández Quero J, Moreno S, García F.
Genotypic Determination of HIV Tropism - Clinical and Methodological Recommendations to Guide the Therapeutic Use of CCR5 Antagonists
AIDS REVIEWS . 12(3): 135-148. Nº de citas: 43
-
Patier de La Peña JL, Norman F, Rodríguez-Ramírez GI, Echániz-Quintana A, Moreno-Cobo MA.
Cervicalgia, tortícolis y poliglobulia como forma de presentación de un hemangioblastoma cerebeloso.
REVISTA CLINICA ESPANOLA . 210(6): .
-
Moreno S, López Aldeguer J, Arribas JR, Domingo P, Iribarren JA, Ribera E, Rivero A, Pulido F.
The future of antiretroviral therapy: challenges and needs
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 65(5): 827-835. Nº de citas: 38
-
Gutiérrez-Cisneros MJ, Cogollos R, López-Vélez R, Martín-Rabadán P, Martínez-Ruiz R, Subirats M, Merino FJ, Fuentes I.
Application of real-time PCR for the differentiation of Entamoeba histolytica and E. dispar in cyst-positive faecal samples from 130 immigrants living in Spain.
ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY . 104(2): 145-149. Nº de citas: 23
-
Steigbigel RT, Cooper DA, Teppler H, Eron JJ, Gatell JM, Kumar PN, Rockstroh JK, Schechter M, Katlama C, Markowitz M, Yeni P, Loutfy MR, Lazzarin A, Lennox JL, Clotet B, Zhao J, Wan H, Rhodes RR, Strohmaier KM, Barnard RJ, Isaacs RD, Nguyen BY, BENCHMRK Study Teamsa.
Long-term efficacy and safety of Raltegravir combined with optimized background therapy in treatment-experienced patients with drug-resistant HIV infection: week 96 results of the BENCHMRK 1 and 2 Phase III trials.
CLINICAL INFECTIOUS DISEASES . 50(4): 605-612. Nº de citas: 172
-
Navas Elorza E, Moreno Guillén S.
Tuberculosis multirresistente y extremadamente resistente.
Revista española de sanidad penitenciaria . 12(3): 91-98.
-
Poveda E, Anta L, Blanco JL, Pérez-Elías MJ, García F, Leal M, Ribera E, Gutiérrez F, Soriano V, de Mendoza C.
Etravirine resistance associated mutations in HIV-infected patients failing efavirenz or nevirapine in the Spanish antiretroviral resistance database.
AIDS . 24(3): 469-471. Nº de citas: 13